Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase.
about
Hexosamines, insulin resistance, and the complications of diabetes: current status.A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferaseMammalian cells contain a second nucleocytoplasmic hexosaminidaseModification-specific proteomics: strategies for characterization of post-translational modifications using enrichment techniquesFunctional O-GlcNAc modifications: implications in molecular regulation and pathophysiologyProteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometryStructure of a bacterial putative acetyltransferase defines the fold of the human O-GlcNAcase C-terminal domainThe hexosamine signaling pathway: deciphering the "O-GlcNAc code"Structure and mechanism of a bacterial beta-glucosaminidase having O-GlcNAcase activityTranscription factor Nrf1 is negatively regulated by its O-GlcNAcylation statusGlucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamineO-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathwayNon-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transitionO-GlcNAcase: promiscuous hexosaminidase or key regulator of O-GlcNAc signaling?O-GlcNAc modifications regulate cell survival and epiboly during zebrafish development.O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stressO-GlcNAc cycling enzymes associate with the translational machinery and modify core ribosomal proteinsO-GlcNAcylation/phosphorylation cycling at Ser10 controls both transcriptional activity and stability of delta-lactoferrin.A Caenorhabditis elegans model of insulin resistance: altered macronutrient storage and dauer formation in an OGT-1 knockout.Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytesO-GlcNAc cycling: emerging roles in development and epigenetics.O-GlcNAc signaling in the cardiovascular system.Roles of the tetratricopeptide repeat domain in O-GlcNAc transferase targeting and protein substrate specificity.Vascular O-GlcNAcylation augments reactivity to constrictor stimuli by prolonging phosphorylated levels of the myosin light chain.O-GlcNAcylation, contractile protein modifications and calcium affinity in skeletal muscle.O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension.Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysisThe E2F-1 associated retinoblastoma-susceptibility gene product is modified by O-GlcNAc.O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.Two O-linked N-acetylglucosamine transferase genes of Arabidopsis thaliana L. Heynh. have overlapping functions necessary for gamete and seed developmentMultiple tissue-specific roles for the O-GlcNAc post-translational modification in the induction of and complications arising from type II diabetes.A lipid-droplet-targeted O-GlcNAcase isoform is a key regulator of the proteasomeO-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar.Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia.A little sugar goes a long way: the cell biology of O-GlcNAc.Roles of glucose in photoreceptor survival.O-linked β-N-acetylglucosamine transferase directs cell proliferation in idiopathic pulmonary arterial hypertension.Chemical approaches to understanding O-GlcNAc glycosylation in the brain.O-GlcNAc signalling: implications for cancer cell biology.The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.
P2860
Q24538581-3C7292FF-CE7E-4E3F-80D5-C5BC1D4B9C80Q24543917-181B329E-9CC4-43B1-87B6-EB932005D3CFQ24603531-5ECB511B-8FB9-4EF6-8BA9-EA0958D634AAQ24628360-0E794D36-7E77-4FB0-91F9-7CC22E24C2F2Q27009399-5E8E5D2A-00AF-4726-977E-DD49316717BAQ27334695-30C516AD-8B72-46F2-B9B9-37B8E717929AQ27680132-89E1D917-BF23-4952-8257-B5C0ED637523Q28284365-AE67F109-6561-46A2-94A5-1ED49C64D623Q28492135-5C4200C7-47C1-42C2-BB6C-69223FEBE7FCQ28507099-3C46CFCF-0D03-40B3-A33A-255B0D95DC95Q28565649-BE6A00B0-77B2-4202-A824-D07165E7675BQ28571140-83EE646D-BC9C-44EE-8A2B-A5868404142BQ28579197-50A022FC-1FE2-4F0A-A382-0322F270CD3AQ30368002-1BFE276C-B2E5-4F1F-8A15-23A2B57E0B43Q33433251-E7F7058F-338A-4A9C-9AAE-BC3E77334F71Q33625265-5AA7243A-956E-40F6-9F4D-B18E55598C17Q33907013-1FFD7031-7331-4E64-9FD5-A75D4A87CE35Q33911287-1DB3DAD0-51E8-408C-A3DE-F8ABFF01FF90Q33913856-532116E3-D0FB-4C48-BEC5-F246998703F4Q34024499-13B9F6DB-4DFB-4C4D-99A5-FB143DAE359DQ34049939-5A317463-782A-48A7-A59C-999B2B2B166EQ34056858-0AE2848A-162A-4253-A26E-8F5AA3AA62BDQ34193954-422FB316-9CF3-483B-AAC6-6D5960D45A30Q34272394-6A56F204-888D-40A3-AFA7-FD33D43A7AAAQ34426366-886448A5-FEA1-4DE2-BF78-4E06C5C98703Q34498193-27C8A919-791B-4ED9-8278-35D96B62C707Q34502637-05F0716F-6102-48C6-BB7B-B2E886A333EAQ34538240-44725DD7-F181-4451-9D80-01DF62C97810Q34598611-99BBBEF1-C09C-45E7-A85C-BACA71FDF373Q34615508-607668D2-4A94-43CE-86AB-86FEA33CBAADQ34683091-3C0B1217-E8DE-4740-BAC8-FD46858B0BD0Q35140884-5A6850CD-1E55-4A1B-B95B-DDD06381611EQ35163991-94AA77B3-0878-4DF9-9663-71A6D26F7EB2Q35183015-1F822CF7-4933-4E3B-B28F-17D46E91A9EEQ35261648-43572E46-C29E-42BC-958C-7389848DC156Q35266544-614D30E6-1C3C-46AA-9C7A-F09D0850B668Q35328516-679052DB-7ED7-4237-A976-33C94A0AD907Q35648339-2CAB2BDE-F435-42A3-B64C-5C50BE2B314FQ35793071-3CFA13EE-A74D-4CF4-B648-4EB2AF5B3696Q35994096-5744852D-CC2C-4685-85A1-9F11B151D77B
P2860
Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Dynamic O-glycosylation of nuc ...... lglucosaminidase, O-GlcNAcase.
@ast
Dynamic O-glycosylation of nuc ...... lglucosaminidase, O-GlcNAcase.
@en
Dynamic O-glycosylation of nuc ...... lglucosaminidase, O-GlcNAcase.
@nl
type
label
Dynamic O-glycosylation of nuc ...... lglucosaminidase, O-GlcNAcase.
@ast
Dynamic O-glycosylation of nuc ...... lglucosaminidase, O-GlcNAcase.
@en
Dynamic O-glycosylation of nuc ...... lglucosaminidase, O-GlcNAcase.
@nl
prefLabel
Dynamic O-glycosylation of nuc ...... lglucosaminidase, O-GlcNAcase.
@ast
Dynamic O-glycosylation of nuc ...... lglucosaminidase, O-GlcNAcase.
@en
Dynamic O-glycosylation of nuc ...... lglucosaminidase, O-GlcNAcase.
@nl
P2093
P356
P1476
Dynamic O-glycosylation of nuc ...... lglucosaminidase, O-GlcNAcase.
@en
P2093
Antony Rosen
Gerald W Hart
James A Mahoney
Keith Vosseller
Lance Wells
P304
P356
10.1074/JBC.M109656200
P407
P577
2002-01-01T00:00:00Z